tldrdailynews.com logo
Tag

Nicotine Pouches

All articles tagged with #nicotine pouches

FDA clears Zyn nicotine pouches as lower-risk alternative to smoking
health13 days ago

FDA clears Zyn nicotine pouches as lower-risk alternative to smoking

The FDA said it would allow Philip Morris to market Zyn nicotine pouches as a lower-risk alternative to cigarettes, approving 20 variants with claims that using Zyn reduces the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema and chronic bronchitis. Regulators see potential population-health benefits, while scientists caution about risks to new users and youth. Philip Morris has been expanding Zyn sales and has lobbied for clearer, faster FDA approvals.

via Yahoo|
#fda#health#nicotine-pouches
FDA clears ZYN nicotine pouches as lower-risk alternative to cigarettes
health13 days ago

FDA clears ZYN nicotine pouches as lower-risk alternative to cigarettes

The FDA authorized 20 ZYN nicotine pouch products (in 3 mg and 6 mg strengths) to be marketed as lower risk than cigarettes, though not as a quit-smoking aid. The approval requires five years of post-market studies on risk perception and youth uptake, with the possibility of reversal if youth use rises. Experts warn nicotine addiction remains a concern and that many users may not fully switch from smoking, even as some flavors appeal to younger people.

via NBC News|
#fda#health#nicotine-pouches
FDA Clears Zyn Nicotine Pouches for Lower-Risk Label
business14 days ago

FDA Clears Zyn Nicotine Pouches for Lower-Risk Label

The FDA cleared 20 Philip Morris–owned Zyn nicotine pouches to carry a modified-risk claim, saying switching from cigarettes lowers the risk of several diseases; this gives the company a major marketing advantage as cigarette sales decline, though the FDA stresses no tobacco product is safe; the products come in 3 mg and 6 mg strengths across multiple flavors.

via CNBC|
#business#fda#modified-risk
FDA Greenlights Lower-Risk Claims for Zyn Nicotine Pouches
health14 days ago

FDA Greenlights Lower-Risk Claims for Zyn Nicotine Pouches

The FDA has allowed 20 Zyn nicotine-pouch products to market claims that using Zyn instead of cigarettes lowers the risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis, based on the totality of evidence. Regulators say the decision helps provide adults who smoke with science-based information about relative harms. The move is a win for PMI and Swedish Match, though critics warn about cardiovascular effects and note many users aren’t former smokers, highlighting ongoing debate about harm reduction and political associations around the product.

via Axios|
#fda#harm-reduction#health
Nicotine's New Brand: Productivity Boost or Health Gamble?
health4 months ago

Nicotine's New Brand: Productivity Boost or Health Gamble?

A wellness and productivity trend around nicotine is surging among biohackers and startups, with products like nicotine pouches marketed as cognitive enhancers and performance tools. While some research suggests potential benefits for certain cognitive impairments, experts say benefits for healthy individuals are likely marginal and addiction risk remains. The FDA has authorized only a couple of nicotine products so far and is taking enforcement action against unapproved items, creating regulatory risk for many brands. The trend raises concerns about nonsmokers and youths starting nicotine, as influencers frame the substance in edgy, health-boosting terms while legacy tobacco companies push similar messaging through branding.

via statnews.com|
#addiction-risk#biohacking#fda-regulation
Rising Use of Zyn Nicotine Pouches Sparks Health Concerns
health1 year ago

Rising Use of Zyn Nicotine Pouches Sparks Health Concerns

Sales of Zyn nicotine pouches are rapidly increasing in the U.S., driven by their discreet, smoke-free design and potential as a safer alternative to smoking, though concerns about youth appeal and addiction persist. The FDA has recently approved marketing for some Zyn products, and the company is expanding production, raising questions about regulation and public health impacts.

via Axios|
#addiction#fda-approval#health
Philip Morris to Open $600M Zyn Plant in Colorado, Adding 500 Jobs
businesseconomy2 years ago

Philip Morris to Open $600M Zyn Plant in Colorado, Adding 500 Jobs

Philip Morris International is investing $600 million in a new Zyn nicotine pouch manufacturing facility in Aurora, Colorado, expected to create 500 local jobs and 5,000 construction jobs. The facility aims to meet the growing demand for smokeless nicotine alternatives and is projected to have a $550 million annual economic impact. The company also announced significant donations to support Colorado veterans and local housing initiatives. Concerns remain about the potential appeal of nicotine pouches to underage users, although current data shows low usage among teens.

via Sentinel Colorado|
#aurora#businesseconomy#job-creation
The Sudden Rise of Zyn Nicotine Pouches.
health3 years ago

The Sudden Rise of Zyn Nicotine Pouches.

Zyn nicotine pouches, a discreet and addictive alternative to cigarettes and vapes, have seen a surge in popularity, with sales exceeding 800 million units in the first three months of 2022. While some see potential for harm reduction, experts caution that there isn't enough data to know about the long-term effects of nicotine pouches as a way to quit smoking or vaping. Additionally, the tobacco industry's marketing of these products as "tobacco-free" can be misleading to consumers, and there are concerns about the potential for gum damage and other health risks associated with long-term use.

via GQ|
#addiction#harm-reduction#health